GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) Peptid
GABARAPL1
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle GABARAPL1 Produkte
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- KAPKARVPDL DKRKYLVPSD LTVGQFYFLI RKRIHLRPED ALFFFVNNTI
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GABARAPL1 antibody,
Alternative Names: GABARAPL1 control peptide, GABARAPL1 antibody Blocking Peptide, Anti-GABARAPL1 Blocking Peptide, Gaba A receptor-associated protein like 1 Blocking Peptide, APG8L Blocking Peptide, ATG8 Blocking Peptide, ATG8L Blocking Peptide, GEC1 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Hintergrund
- GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
- Molekulargewicht
- 14 kDa
-
Sie sind hier:
